Leonard D. White

Internal Medicine

1 Medical Park
Wheeling, WV 26003

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

Quantifying the dark data in museum fossil collections as palaeontology undergoes a second digital revolution.

Quantifying the dark data in museum fossil collections as palaeontology undergoes a second digital revolution.

Journal: Biology letters

Published: June 13, 2018

Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS).

Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS).

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: August 15, 2014

ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer.

ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 09, 2013

Subscale structure for the Positive and Negative Syndrome Scale (PANSS): a proposed solution focused on clinical validity.

Subscale structure for the Positive and Negative Syndrome Scale (PANSS): a proposed solution focused on clinical validity.

Journal: Psychiatry research

Published: March 29, 2012

Showing 1-4 of 4

Last Updated: 09/26/2026